Search

Search Results
Results 101 - 110 of 311 for Gastrointestinal
  • Somac Heartburn Relief
    Drug - 17 Aug 2022
    Consumer Medicine Information (CMI) about Somac Heartburn Relief (pantoprazole sodium sesquihydrate) intended for persons living in Australia.
  • Xelabine
    Drug - 1 Jul 2022
    Consumer Medicine Information (CMI) about Xelabine (capecitabine) intended for persons living in Australia.
  • Dalacin C Phosphate Injection
    Drug - 9 Feb 2022
    Consumer Medicine Information (CMI) about Dalacin C Phosphate Injection (Clindamycin phosphate) intended for persons living in Australia.
  • Lincocin
    Drug - 22 Apr 2020
    Consumer Medicine Information (CMI) about Lincocin (lincomycin hydrochloride monohydrate) intended for persons living in Australia.
  • Dulcolax Suppositories
    Drug - 20 Dec 2018
    Consumer Medicine Information (CMI) about Dulcolax Suppositories (Bisacodyl) intended for persons living in Australia.
  • Ryzodeg 70/30 Penfill
    Drug - 16 Apr 2025
    Consumer Medicine Information (CMI) about Ryzodeg 70/30 Penfill (70% insulin degludec / 30% insulin aspart) intended for persons living in Australia.
  • 3TC Oral Solution
    Drug - 14 Apr 2025
    Consumer Medicine Information (CMI) about 3TC Oral Solution intended for persons living in Australia.
  • Ziagen Oral Solution
    Drug - 8 Apr 2025
    Consumer Medicine Information (CMI) about Ziagen Oral Solution intended for persons living in Australia.
  • Ziagen Tablets
    Drug - 8 Apr 2025
    Consumer Medicine Information (CMI) about Ziagen Tablets intended for persons living in Australia.
  • Mersyndol Forte
    Drug - 7 Apr 2025
    Consumer Medicine Information (CMI) about Mersyndol Forte intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback